Q&A with Ravi Bhatia, MD
In January 2015, Ravi Bhatia, M.D., joined the UAB Department of Medicine as director of the Division of Hematology and Oncology. Bhatia spent the past eight years as director of the Division of Hematopoietic Stem Cell and Leukemia Research at City of Hope, in Duarte, California, one of the nations’ most successful leukemia treatment centers. Here, he answers a few questions about his new role at UAB. Read More...
March 2015 Research Spotlight:
Fadi Hage, MDDr. Hage is Associate Professor of Medicine in the Division of Cardiovascular Disease, Director of Nuclear Cardiology at UAB, and Director of the Cardiac Care Unit at the BVAMC. He is also a member of the Vascular Biology and Hypertension Program.
In 2014, Dr. Hage and collaborators demonstrated that the effects of estrogen therapy on vascular inflammation are age dependent. In 2002, the Women’s Health Initiative (WHI) reported increased cardiovascular events in women treated with menopausal hormones compared to placebo. These results were in contrast to the well-established anti-inflammatory and vasoprotective effects of 17β-Estradiol (E2) seen in in vitro preparations, young adult laboratory animals, and observational studies in pre- and peri-menopausal women. Importantly, WHI enrolled older women than the observational studies.
TRS Winners to present March 23rd CRS